Indirect muscarinic receptor activation by pentamidine on airway smooth muscle

British Journal of Pharmacology

Volumn 119, Issue 6, 1996, Pages 1131-1136

  Biyah, Keltoum ^a   Molimard, Mathieu ^a   Naline, Emmanuel ^a   Bazelly, Bernard ^b   Advenier, Charles ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Centre Chirurgical Val d'Or   (France)

Author keywords

Airway smooth muscle; Muscarinic receptor; Pentamidine

Indexed keywords

2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; ACETYLCHOLINE; ANTIPROTOZOAL AGENT; ARACHIDONIC ACID DERIVATIVE; ATROPINE; CHOLINESTERASE INHIBITOR; HEXAHYDROSILADIPHENIDOL; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE RECEPTOR; INDOMETACIN; MEPYRAMINE; MORPHINE; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC M3 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR; PENTAMIDINE ISETHIONATE; PIRENZEPINE; SR 48969; TACHYKININ; TACRINE; UNCLASSIFIED DRUG;

AIRWAY; ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; BRONCHUS; CHOLINERGIC NERVE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COUGHING; DRUG POTENTIATION; FEMALE; GUINEA PIG; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MALE; NERVE STIMULATION; NONHUMAN; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SMOOTH MUSCLE;

EID: 0029953442     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16014.x     Document Type: Article

References (19)

1. ALTSON, T.A. (1988). Inhibition of cholinesterases by pentamidine. Lancet, ii, 1423.
2. BELVISI, M.G., STRETTON, D. & BARNES, P.J. (1990). Modulation of cholinergic neurotransmission in guinea-pig airway by opioids. Br. J. Pharmacol., 100, 131-137.
3. CHOO, L.K. & MITCHELSON, F.J. (1985). Comparison of the affinity constant of some muscarinic receptor antagonists with their displacement of [3H] quinuclidinyl benzilate binding in atrial and ileal longitudinal muscle of the guinea-pig. J. Pharm. Pharmacol., 37, 656-658.
4. DEBS, R., BRUNETTE, E., FUCHS, H., LIN, E., SHAH, M., HARGIS, A. & MONTGOMERY, B. (1990). Biodistribution, tissue reaction, and lung retention of pentamidine aerosolized as three different salts. Am. Rev. Respir. Dis., 142, 1164-1167.
5. DIXON, M., JACKSON, D.M. & RICHARDS, I.M. (1980). The action of sodium cromoglycate on C fibre endings in dog lung. Br. J. Pharmacol., 70, 11-13.
6. EGLEN, R.M., REDDY, H., WATSON, N. & CHALLISS, R.A.J. (1994). Muscarinic acetylcholine receptor subtypes in smooth muscle. Trends Pharmacol. Sci., 15, 115-119.
7. FLYNN, D.L., RAFFERTY, M.F. & BOCTOR, A.M. (1986). Inhibition of human neutrophil 5-lipoxygenase activity by gingerdione, shogaol, capsaicin and related pungent compounds. Prostaglandins Leuk. Med., 24, 195-198.
8. FULLER, R.W., DIXON, C.M.S. & BARNES, P.J. (1985). Bronchoconstrictor response to inhaled capsaicin in humans. J. App Physiol., 58, 1080-1084.
9. JARREAU, P.-H., HARF, A., LEVAME, M., BOYER, V., LORINO, H. & MACQUIN-MAVIER, I. (1993). Involvement of tachykinins in pentamidine-induced airway constriction and microvascular leakage in guinea pig. Am. Rev. Respir. Dis., 147, 1544-1549.
10. JUAN, H., LEMBECK, F., SEEWANN, S. & HACK, U (1980). Nociceptor stimulation and PGE release by capsaicin. Naunyn-Schmiedeberg's Arch. Pharmacol., 312, 139-143.
11. KENAKIN, T. (1993). Competitive antagonism. In Pharmacologic Analysis of Drug-Receptor Interaction. ed. Kenakin, T. pp. 278-322. New York: Raven Press.
12. LEVINE, R.R. & BIRDSALL, N.J.M. (1989). Subtypes of muscarinic receptors IV. Trends Pharmacol. Sci., 10 Suppl., VII.
13. LÖTVALL, J.O., SKOOGH, B.-E., LEMEN, R.J., ELWOOD, W., BARNES, P.J. & CHUNG, K.F. (1990). Bronchoconstriction induced by inhaled sodium metabisulfite in the guinea pig. Am. Rev. Respir. Dis., 142, 1390-1395.
14. MAGGI, C.A., PATACCHINI, R., BAROLDI, P., THEODORSSON, E. & MELI, A. (1990). Immunoblockade by specific tachykinin antiserum of the non-cholinergic contractile responses in the guinea-pig isolated bronchus. J. Auton. Pharmacol., 10, 173-179.
15. MAPP, C.E., FABBRI, L.M., BONIOTTI, A. & MAGGI, C.A. (1991). Prostacyclin activates tachykinin release from capsaicin-sensitive afferents in guinea-pig bronchi through a ruthenium red-sensitive pathway. Br. J. Pharmacol., 104, 49-52.
16. MASUR, H. (1992). Prevention and treatment of pneumocystis pneumonia. N. Engl. J. Med., 327, 1853-1860.
17. MOLIMARD, M., MARTIN, C.A.E., NALINE, E., HIRSCH, A. & ADVENIER, C. (1994). Contractile effects of bradykinin on the isolated human small bronchus. Am. J. Respir. Crit. Care Med., 149, 123-127.
18. MONTGOMERY, A.B., FEIGAL, D.W. SATTLER, J.R.F., MASON, G.R., CATANZARO, A., EDISON, R., MARKOWITZ, N., JOHNSON, E., OGAWA, S., ROVZAR, M., UDEM, S.A., EDEN, E., HYSLOP, N., CHEUNG, T.W., KESSLER, H., MILDVAN, D., GIRON, J.A., ETTINGER, N., CRUMPACKR, C., FRAME, P., STEIGBIGEL, N., VAN DER HORST, C., HIRSCH, M., LEDERMAN, M.M., HEWITT, R.G., FALLAT, R., FARBER, H.W., SACKS, H.S., EISMAN, S.A., LUCE, J.M., BOYLAN, T., ADAMS, M., FEINBERG, J., HOPEWELL, P.C. (1995). Pentamidine aerosol versus trimethoprim-sulfamethoxazole for pneumocystis carinii in acquired immune deficiency syndrome. Am. J. Respir. Crit. Care Med., 151, 1068-1074.
19. TORONTO AEROSOLIZED PENTAMIDINE STUDY (TAPS) GROUP (1990). Acute pulmonary effects of aerosolized pentamidine. Chest, 98, 907-910.